Clinical Trial Update: Prophylactic PIPAC in Patients With High-risk Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating prophylactic PIPAC in high-risk colorectal cancer patients; the study status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Jeremy Meyer | Conditions: Colorectal Cancer Control and Prevention, Colorectal Cancer | Phase 3 | Status: NOT_YET_RECRUITING